The PATHFINDER study: assessment of the implementation of an investigational multi-cancer early detection test into clinical practice
LD Nadauld, CH McDonnell III, TM Beer, MC Liu… - Cancers, 2021 - mdpi.com
Simple Summary PATHFINDER is an interventional study that will examine how well a multi-
cancer early detection test can be integrated into clinical practice. This test looks at DNA …
cancer early detection test can be integrated into clinical practice. This test looks at DNA …
[PDF][PDF] The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice. Cancers. 2021; 13 …
LD Nadauld, CH McDonnell 3rd, TM Beer… - DOI: https://doi. org …, 2021 - academia.edu
To examine the extent of the evaluation required to achieve diagnostic resolution and the
test performance characteristics of a targeted methylation cell-free DNA (cfDNA)-based multi …
test performance characteristics of a targeted methylation cell-free DNA (cfDNA)-based multi …
An exploratory analysis of the cost-effectiveness of a multi-cancer early detection blood test in Ontario, Canada
D Lewis - 2023 - uwspace.uwaterloo.ca
Background: Cancer is one of the main causes of death globally and early detection of
tumors through screening is key to preventing morbidity and mortality. However, screening …
tumors through screening is key to preventing morbidity and mortality. However, screening …